IBIO (iBio, Inc.) Short-Term Debt to Capital
The market value of iBio, Inc. (IBIO), which stands at 0.01 as illustrated on this chart, is supported by the bioplatform's independence from market volatility and strong interest in AI-driven cancer therapy. The business generates revenue through antibody development and licensing deals with industry behemoths. Simultaneously, iBio, Inc. (IBIO) is implementing sustainable production methods, minimizing harmful emissions and strictly adhering to ethical research standards.
Analytical breakdowns for iBio, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:iBio Corp
A conservative investor assesses the stability of iBio, Inc. (IBIO) through the ratio of current liabilities to net assets, where the trend of debt under one year relative to equity reflects liquidity risk. For a company scaling its RubrYc AI platform for B2B licenses, this indicator determines the balance between aggressive market capture in immunopharmaceuticals and the ability to service short-term loans without the threat of default.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Septerna Pharma SEPN|PVLA: Short-Term Debt to Capital|SVRA (savarapharma.com) - Short-Term Debt to Equity|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|AnaptysBio Inc (ANAB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Astria Pharma (ATXS)|ENGN - Current Liabilities to Capital|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital JBIO|Aclaris Therapeutics, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences PLC (TLSA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio CABA|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio theratech.com (THTX)|Short-Term Debt to Equity Ratio AVTX (Avalo Therapeutics)|Short-Term Debt to Capital Coefficient Eledon Pharmaceuticals Inc.|Short-Term Debt to Capital AGEN (Agenus Inc)|Short-Term Debt to Capital Coefficient Climb Bio, Inc (CLYM)|Zura Bio - Short-Term Debt to Capital|ATYR: Short-Term Debt to Equity|ADAG: Short-Term Debt to Capital|IMA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Shattuck Labs Inc|Current Liabilities to Capital Equillium Bio EQ|Short-Term Debt to Equity Connect Biopharma (CNTB)|IMUX: Current Liabilities to Equity|Short-Term Debt to Capital ATRA (Atara Bio)|Ratio of Short-Term Indebtedness to Capital IFRX|X4 Pharma - Short-Term Debt to Capital|ACET - Short-Term Debt to Capital|celularity.com (CELU) - Short-Term Debt to Equity|inmunebio.com - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Barinthus Biotherapeutics plc|Short-Term Debt to Equity Ratio Kezar Life Sciences Inc. (KZR)|Short-Term Debt to Capital SABS|Short-Term Debt to Capital Akari Therapeutics, Plc (AKTX)|Enlivex Therapeutics Ltd. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital QTTB|GeoVax - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Edesa Biotech Inc EDSA|carismatx.com (CARM) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio XTL Bio|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Equity Ratio HCW Biologics Inc (HCWB)|Short-Term Debt to Equity Ratio APVO (Aptevo Therapeutics)|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Equity Aditxt, Inc. ADTX|GRI: Short-Term Debt to Capital Ratio|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Current Liabilities to Capital reshapelifesciences.com|REVB: Short-Term Debt to Capital|INDP - Short-Term Debt to Capital Coefficient|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Equity CALI|Short-Term Debt to Capital AFMD|Short-Term Debt to Capital Coefficient allakos.com|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGM Biosciences Inc. (IGMS) - Current Liabilities to Capital|ITOS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TCBP: Short-Term Debt to Capital|THRD - Short-Term Debt to Capital Coefficient